JMS-17-2 is primarily used in research and development within the pharmaceutical industry, particularly in the study of cancer therapeutics. It functions as a selective inhibitor targeting specific cellular pathways involved in tumor growth and proliferation. Researchers utilize this compound to investigate its potential in suppressing cancer cell viability and inducing apoptosis in various cancer models. Its application extends to preclinical studies, where it helps in understanding the mechanisms of action and efficacy of novel anticancer agents. Additionally, JMS-17-2 is employed in biochemical assays to explore its interaction with molecular targets, aiding in the design of more effective and targeted cancer treatments.